GMED Valuation

Globus Medical Inc

Add to Watchlist

Advanced Chart

71.200

+0.220(+0.310%)

Overview
Forecast
Valuation

GMED Relative Valuation

GMED's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GMED is overvalued; if below, it's undervalued.

Historical Valuation

Globus Medical Inc (GMED) is now in the Undervalued zone, suggesting that its current forward PE ratio of 20.81 is considered Undervalued compared with the five-year average of 28.70. The fair price of Globus Medical Inc (GMED) is between 79.03 to 119.76 according to relative valuation methord. Compared to the current price of 71.20 USD , Globus Medical Inc is Undervalued By 9.90%.

Relative Value

Fair Zone

79.03-119.76

Current Price：71.20

9.90%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.36

P/B

Median3y

2.79

Median5y

3.35

0.00

FCF Yield

Median3y

2.20

Median5y

2.31

Competitors Valuation Multiple

The average P/S ratio for GMED's competitors is 2.95, providing a benchmark for relative valuation. Globus Medical Inc Corp (GMED) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 6.61%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap